Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Senti

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Investigational Allergology & Clinical Immunology|November 26, 2003
Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollenB Wüthrich, Ch Bucher, W Jörg, et al.
Allergy|December 17, 2008
Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapyJ M Martínez-Gómez, P Johansen, H Rose, et al.
Rhinology|June 17, 2014
A critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trialsN Graf, B Dinkel, H Rose, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapyP Johansen, G Senti, J M Martinez Gomez, et al.
Allergy|December 21, 2013
IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitizationC Uermösi, F Zabel, V Manolova, et al.
The Journal of Clinical Investigation|June 8, 2001
T-cell involvement in drug-induced acute generalized exanthematous pustulosisM Britschgi, U C Steiner, S Schmid, et al.
Dermatology (Basel, Switzerland)|October 13, 2006
Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatmentG Senti, L S Steinmann, B Fischer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 20, 2009
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trialG Senti, P Johansen, S Haug, et al.
European Journal of Immunology|February 1, 2005
Direct intralymphatic injection of peptide vaccines enhances immunogenicityP Johansen, A C Häffner, F Koch, et al.
Allergy|June 18, 2014
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccineA Zaleska, T Eiwegger, O Soyer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Investigational Allergology & Clinical Immunology|November 26, 2003
Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollenB Wüthrich, Ch Bucher, W Jörg, et al.
Allergy|December 17, 2008
Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapyJ M Martínez-Gómez, P Johansen, H Rose, et al.
Rhinology|June 17, 2014
A critical appraisal of analyzing nasal provocation test results in allergen immunotherapy trialsN Graf, B Dinkel, H Rose, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2006
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapyP Johansen, G Senti, J M Martinez Gomez, et al.
Allergy|December 21, 2013
IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitizationC Uermösi, F Zabel, V Manolova, et al.
The Journal of Clinical Investigation|June 8, 2001
T-cell involvement in drug-induced acute generalized exanthematous pustulosisM Britschgi, U C Steiner, S Schmid, et al.
Dermatology (Basel, Switzerland)|October 13, 2006
Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatmentG Senti, L S Steinmann, B Fischer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 20, 2009
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trialG Senti, P Johansen, S Haug, et al.
European Journal of Immunology|February 1, 2005
Direct intralymphatic injection of peptide vaccines enhances immunogenicityP Johansen, A C Häffner, F Koch, et al.
Allergy|June 18, 2014
Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccineA Zaleska, T Eiwegger, O Soyer, et al.
Pageof 4